Department of Critical care medicine of West China Hospital
Chengdu, Sichuan, 610041, China
Location status: Recruiting
Location contact
Y F Zhou, MM
PRINCIPAL_INVESTIGATOR
Y F zhou, MM
CONTACT
Y Y Yang, MM
CONTACT
NCT Number: NCT06586736
The purpose of this study is to observe the changes of physiological indicators such as ventilation and oxygenation in the prone position of ARDS patients, to observe the change trend of each patient's indicators, and to observe whether different trends of indicators predict different prognosis of patients.
Interested in participating?
Request Info18 year–90 year
All sexes
Observational
Chengdu, Sichuan, 610041, China
Location status: Recruiting
Y F Zhou, MM
PRINCIPAL_INVESTIGATOR
Y F zhou, MM
CONTACT
Y Y Yang, MM
CONTACT
PP has been shown to effectively improve the prognosis of patients with severe ARDS, but not all patients with ARDS can benefit from PP, and the implementation of the PP has a certain clinical risks and side effects, we lack a convenient predictors to guide doctors to determine whether patients should implement the PP. Clinical usually observe the P/F improved as whether PP treatment effective reference, but there are literature points out that the rising P/F after PP can not predict the better prognosis. one of the mechanisms for ARDS patients benefit from PP is proved to be improve V/Q, the change of the V/Q may determine whether the PP treatment effectively is an important indicator. PaO2:FiO2 ratio was usually used to evaluate the effect of PP, but some studies did not support this conclusion. PP has been shown to change ventilation-perfusion ratio, dead space may be better physiological indicators, simplify dead space ratio and Ventilatory ratio can be easily accessed at bedside and is associated with mortality of patients with ARDS. The purpose of this study is to observe the predictive value of P/F, VD-etCO2/VT, and VR on the treatment effect of ARDS undergoing PP.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From the date of enrollment to 28 days
Days without mechanical ventilation support within 28 days after enrollment
Time frame: From the date of enrollment until the date of discharge, assessed up to 1 year
Prognostic measures will be recorded until discharge, such as ICU mortality and in-hospital mortality
Time frame: From the date of enrollment until the date of discharge, assessed up to 1 year.
Prognostic measures will be recorded until discharge, such as length of lICU stay and length of hospital stay in days.
Time frame: From enrollment to Day 7.
Respiratory physiological parameters are collected at each time point (before prone positioning , every 4 hours after prone positioning, and 4 hours after turn back to supine position), such as PaO2/FiO2。
Time frame: From enrollment to Day 7.
Indicators related to dead space are collected at each time point (before prone positioning , every 4 hours after prone positioning, and 4 hours after turn back to supine position), such as VR and dead space ratio, which were calculated by predicted body weight, partial pressure of carbon dioxide and end-tidal carbon dioxide
West China Hospital
Other
The Respiratory Physiologic Efficacy of Prone Position and Its Association With Outcomes in ARDS: A Prospective Observational Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06919484
Acute Respiratory Distress Syndrome, Lung Diseases
Nanjing, Jiangsu, China
View Trial DetailsNCT06148467
Acute Respiratory Distress Syndrome, Lung Diseases
Guadalajara, Mexico
View Trial DetailsNCT01089400
Acute Lung Injury, Acute Respiratory Distress Syndrome
Paris, France
View Trial DetailsNCT05922631
Acute Respiratory Distress Syndrome, Cardiovascular Diseases
Wuhan, Hubei, China
View Trial Details